Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-15

FDA Approved: ARSENIC TRIOXIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for arsenic trioxide from Ingenus Pharmaceuticals, LLC, enabling its generic product to be marketed for acute promyelocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arsenic Trioxide (arsenic trioxide)

Snippet

SUPPL AP for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE)